Organigram Global Inc. balance sheet

At the end of fiscal 2025, Organigram Global Inc. had total assets of $404m, total liabilities of $153m and shareholders' equity of $251m. It held $60.0m in cash against $17,951 of debt: net cash of $60.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Organigram Global Inc.: balance sheet, annual
Fiscal year	2018Aug 2018	2019Aug 2019	2020Aug 2020	2021Aug 2021	2022Aug 2022	2023Sept 2023	2024Sept 2024	2025Sept 2025
Cash and equivalents	—	—	—	—	—	38	98	60
Receivables	—	—	—	—	—	22	27	47
Inventory	34	70	51	29	38	47	50	76
Total current assets	155	148	131	206	169	115	194	205
Goodwill	—	—	—	—	—	—	0	38
Total assets	231	322	334	439	441	221	302	404
Total current liabilities	9	33	22	21	42	17	39	91
Short-term debt	0	3	9	0	0	0	0	0
Long-term debt	2	35	80	0	0	0	0	0
Total debt	3	37	88	0	0	0	0	0
Total liabilities	90	76	104	59	53	20	75	153
Shareholders' equity	141	246	230	380	388	201	226	251
Net debt (negative = net cash)	—	—	—	—	—	−38	−98	−60
Shares outstanding	—	—	—	75m	78m	81m	109m	134m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BTMD vs OGI KMDA vs OGI CRON vs OGI

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Organigram Global Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Organigram Global Inc.